Skip to main content
. 2020 Dec 1;22(12):e17487. doi: 10.2196/17487

Table 1.

Patient demographics.

Factors All patients Group A
(2-year death)
Group B
(2-year survival)
P value
Patients, N 232 81 151 N/Aa
Age (years), mean (SD) 85.4 (4.2) 85.8 (4.0) 85.3 (4.3) .41
Sex (male), n (%) 109 (47) 36 (44) 73 (48) .57
Diabetes mellitus, n (%) 130 (56) 51 (62) 79 (52) .12
Hypertension, n (%) 201 (87) 72 (89) 129 (85) .46
Coronary artery disease, n (%) 93 (40) 32 (40) 61 (40) .90
Congestive heart failure, n (%) 39 (17) 19 (24) 20 (13) .047
Cerebrovascular accident, n (%) 52 (22) 29 (36) 22 (15) <.001
Dialysis dependence, n (%) 57 (25) 27 (33) 30 (20) .02
Smoking history, n (%) 58 (25) 19 (24) 39 (26) .69
Atrial fibrillation, n (%) 49 (21) 20 (25) 29 (19) .33
Hyperlipidemia, n (%) 95 (41) 31 (39) 64 (42) .59
Ambulatory status, n (%) 83 (36) 16 (20) 67 (44) <.001
CLTIb, n (%) 192 (83) 78 (96) 114 (76) <.001
Body mass index (kg/m2), mean (SD) 23.1 (3.5) 22.3 (3.5) 23.6 (3.4) .006
Cholesterol (mg/dL), mean (SD) 159 (39) 150 (39) 163 (39) .01
Triglyceride (mg/dL), mean (SD) 117 (70) 111 (63) 119 (73) .46
Glycohemoglobin (%), mean (SD) 6.51 (1.50) 6.70 (1.68) 6.42 (1.41) .21
Hematocrit (%), median (IQR) 33.7 (29.8-37.2) 33.5 (29.9-36.5) 33.9 (29.8-38.1) .10
White blood cell count (109/L), median (IQR) 7.230 (5.673-9.080) 7.970 (6.720-9.965) 6.850 (5.120-8.200) .001
Platelet count (103/μL), median (IQR) 208 (164-255) 217 (169-278) 205 (156-245) .07
Neutrophil-lymphocyte ratio, median (IQR) 3.62 (2.34-5.62) 5.03 (3.31-7.02) 3.03 (2.04-4.64) <.001
Platelet-lymphocyte ratio, median (IQR) 145 (114-219) 173 (120-243) 135 (107-195) .002
Systemic immune-inflammation indexc, median (IQR) 716 (461-1272) 1083 (568-1835) 598 (383-972) <.001
C-reactive protein (mg/dL), median (IQR) 1.25 (0.31-4.40) 3.08 (0.77-8.20) 0.90 (0.19-2.92) <.001
Albumin (g/dL), mean (SD) 3.10 (0.65) 2.78 (0.63) 3.26 (0.59) <.001
CONUTd score, mean (SD) 4.74 (2.97) 6.26 (2.81) 3.93 (2.72) <.001
Geriatric Nutritional Risk Index, mean (SD) 89.3 (12.5) 83.1 (12.3) 92.6 (11.3) <.001
Follow-up time (days), median (IQR) 971 (389-1575) 229 (79-438) 1360 (1008-1942) <.001

aN/A: not applicable.

bCLTI: chronic limb-threatening ischemia.

cSystemic immune-inflammation index was defined as (platelet count × neutrophil count)/lymphocyte count.

dCONUT: Controlling Nutritional Status.